p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas.
暂无分享,去创建一个
Arnold J Levine | A. Levine | A. Stoffel | Bhuvanesh Singh | P. Rao | S. Dao | Bhuvanesh Singh | Pabbathi G Reddy | Andy Goberdhan | Christine Walsh | Su Dao | Ivan Ngai | Ting Chao Chou | Pornchai O-Charoenrat | Pulivarthi H Rao | Archontoula Stoffel | P. O-Charoenrat | Ivan Ngai | A. Goberdhan | C. Walsh | P. Reddy | T. Chou | Archontoula Stoffel
[1] J. Shah,et al. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. , 2001, Cancer research.
[2] N. Zhao,et al. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Inazawa,et al. Comparative genomic hybridization of squamous cell carcinoma of the esophagus: The possible involvement of the DP1 gene in the 13q34 amplicon , 1999, Genes, chromosomes & cancer.
[4] T. Mak,et al. Regulation of PTEN transcription by p53. , 2001, Molecular cell.
[5] Soma Das,et al. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma , 2001, International journal of cancer.
[6] D. K. Bhuyan,et al. Growth factor receptor gene and protein expressions in the human lens , 2000, Mechanisms of Ageing and Development.
[7] F. McCormick,et al. Phosphoinositide 3-OH Kinase (PI3K) and PKB/Akt Delay the Onset of p53-mediated, Transcriptionally Dependent Apoptosis* , 1999, The Journal of Biological Chemistry.
[8] L. Cantley,et al. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[9] D. Notterman,et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. , 2000, Genes & development.
[10] F. Quelle,et al. DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway. , 2001, Blood.
[11] G. Thomas,et al. P53 gene alterations in human tumors: perspectives for cancer control. , 1997, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[12] S. R. Datta,et al. Cellular survival: a play in three Akts. , 1999, Genes & development.
[13] N. Hacker,et al. Anti–sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell–adhesion and tumorigenicity in ovarian cancer cells , 2000, International journal of cancer.
[14] A. J. Levine. The p53 tumor-suppressor gene. , 1992, The New England journal of medicine.
[15] L. Pirola,et al. Structure and function of phosphoinositide 3-kinases. , 1998, Biochimica et biophysica acta.
[16] Joe W. Gray,et al. PIK3CA is implicated as an oncogene in ovarian cancer , 1999, Nature Genetics.
[17] P. Shaw,et al. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[18] Chen-Yang Shen,et al. PIK3CA as an oncogene in cervical cancer , 2000, Oncogene.
[19] A. Stoffel,et al. Chromosome 18 breakpoint in t(11;18)(q21;q21) translocation associated with MALT lymphoma is proximal to BCL2 and distal to DCC , 1999, Genes, chromosomes & cancer.
[20] Jing Li,et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.
[21] S. Knuutila,et al. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma , 1998, Genes, chromosomes & cancer.
[22] S. Knuutila,et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. , 1998, The American journal of pathology.
[23] W. Sellers,et al. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[24] T. Chou,et al. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.
[25] Taylor Murray,et al. Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.
[26] B D Kahan,et al. Computerized quantitation of immunosuppressive synergy for clinical protocol design. , 1994, Transplantation proceedings.